CoChat

Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five

Chagas, Caroline Manto, Moss, Sara, Alisaraie, Laleh · 2018 · International Journal of Pharmaceutics
Cited by 233

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No Caption available. Abstract Many studies have shown that toxicities of anticancer drugs and their adverse effects are related to their chemical structure and high molecular weight that may result in a number of metabolites interacting with drug off‐target networks. These factors require further attention for advancing cancer treatment and decreasing toxicities caused by the molecular complexity of antineoplastic agents. Providing more target‐selective and tolerable cancer therapy with fewer side effects would not only improve patients’ compliance, but also would decrease cancer‐remission rates. This review presents several antineoplastic agents and their metabolites with molecular weights greater than 500 g/mol, which reportedly cause more than fifteen types of adverse reactions during breast cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2018.07.046

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 233

Metadata

Authors
Chagas, C. M., Moss, S., & Alisaraie, L.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2018-10
Volume
549
Issue
1-2
Pages
133-149
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2883308915
Cited by
233
References
8
FWCI
12.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.07.046
The paper
Chagas, C. M., Moss, S., & Alisaraie, L. (2018). Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.07.046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.